BioPharma Dive
SEPTEMBER 18, 2023
Public health officials, as well as drugmakers, are trying to raise awareness of RSV among older adults at risk, and convince them to get an additional respiratory shot alongside those for COVID and flu.
STAT
SEPTEMBER 29, 2023
The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
SEPTEMBER 22, 2023
Despite lower-than-expected demand for a competing treatment, DBV’s chief medical officer says the company’s topical skin patch could be a game-changing option for patients.
Pharma Times
SEPTEMBER 7, 2023
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries - News - PharmaTimes
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
SEPTEMBER 21, 2023
A plan to make HIV prevention drug Pre-Exposure Prophylaxis (PrEP) more widely available will be published before the end of the year, health minister Neil O’Brien has said. And he confirmed that the roadmap would explore whether the drug, which is used to reduce the chance of contracting HIV, could be made available from community […] The post Roadmap exploring PrEP access through pharmacies to be published by year end appeared first on The Pharmacist.
European Pharmaceutical Review
SEPTEMBER 12, 2023
As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. The participants were: Dr Tim Sandle, Head of GxP Compliance at Bio Products Laboratory Limited (BPL) as moderator; Dr Edward Tidswell, Executive Director within the Microbiological Quality and Sterility Assurance organisation of Merck & Co; Frederic Ayers, Research Scienti
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
SEPTEMBER 27, 2023
On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.
PharmaVoice
SEPTEMBER 19, 2023
This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.
Pharma Times
SEPTEMBER 28, 2023
Collaboration will enable teams across the organisation to increase clinical research innovation - News - PharmaTimes
The Pharmacist
SEPTEMBER 7, 2023
The ‘unprecedented challenges’ faced by community pharmacies will be spotlighted at a Westminster debate next week. Conservative MP for Waveney Peter Aldous has secured a debate at Westminster Hall on the afternoon of Thursday 14 September on the ‘future of community pharmacies’. Confirming the news, Community Pharmacy England (CPE) said this provided a ‘very good […] The post Westminster debate to spotlight 'unprecedented challenges' in community pharmacy appeared first on The P
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
SEPTEMBER 7, 2023
In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions at Advanz Pharma and Mokhtar Elsayed, head of global go to market commercial transformation at Sano
EMCrit Project
SEPTEMBER 28, 2023
background Today the Van de Bergh group in Belgium released a RCT investigating tight versus liberal glycemic control in the ICU. Before diving into this study, let's take a walk down memory lane. Major interest in tight glycemic control in the ICU began in 2001 with an RCT by the same group of investigators, also […] EMCrit Project by Josh Farkas.
STAT
SEPTEMBER 26, 2023
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous
PharmaVoice
SEPTEMBER 18, 2023
An effort to spare the species from blood collection is one of many ways the industry is turning away from animals for R&D.
Pharma Times
SEPTEMBER 8, 2023
The company will use its AI technology during a sub-study to analyse the effect of lansoprazole - News - PharmaTimes
The Pharmacist
SEPTEMBER 14, 2023
Community pharmacies in Scotland will be able to participate in a national naloxone emergency supply service from the end of next month. The Royal Pharmaceutical Society (RPS) in Scotland described the move as a ‘huge step forwards’ in making naloxone, which is used to reverse the effects of an opioid overdose, available in all clinical […] The post Scotland introduces national naloxone emergency supply appeared first on The Pharmacist.
BioPharma Dive
SEPTEMBER 11, 2023
The HER3-targeting treatment could become the next antibody-drug conjugate to emerge from Daiichi Sankyo’s laboratories, after the AstraZeneca-partnered Enhertu.
Pharmafile
SEPTEMBER 15, 2023
GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK plans to invest £15m in the partnership, with the two companies working together to increase rates of childhood vaccination. The partnership aims to reduce the number of ‘zero dose’ children in Ethiopia and Nigeria, meaning […] The post GSK and Save the Children extend partnership for unvaccinated children appeared first on Pharmafile.
STAT
SEPTEMBER 22, 2023
In a new test of xenotransplantation , a medical team at the University of Maryland Medical Center announced Friday that, for only the second time in history, it had transplanted a heart from a genetically engineered pig into a human. The surgeons performed the eight-hour procedure Wednesday without complications. As of Friday afternoon, the organ recipient, a 58-year-old Navy veteran and former vaccine researcher at the National Institutes of Health named Lawrence Faucette, is awake, able to si
PharmaVoice
SEPTEMBER 25, 2023
Despite high rates of disease in older populations, systemic issues are keeping them out of research studies.
Pharma Times
SEPTEMBER 1, 2023
The AI platform and expertise will be combined to discover novel targets for haematological cancers - News - PharmaTimes
The Pharmacist
SEPTEMBER 1, 2023
Pharmacists working as online prescribers should beware the ‘red flag’ of a patient refusing to allow them to contact their GP, the Pharmacists’ Defence Association (PDA) has warned. It has issued guidance to pharmacist prescribers working in online settings to minimise risk both to themselves and to their patients. And it urged the General Pharmaceutical […] The post Online pharmacies warned over risks of not contacting GPs appeared first on The Pharmacist.
European Pharmaceutical Review
SEPTEMBER 15, 2023
The CBL-0201DD Phase II study evaluating the first-in-class small-molecule drug CBL-514 for Dercum’s disease, a rare disorder, has demonstrated significant efficacy in reducing lipoma size and complete clearance. Dercum’s disease is characterised by painful lipomas developing primarily on the trunk in the body. Currently there are no approved or effective medicine, so the data from the Phase II study shows potential of a treatment for this indication.
BioPharma Dive
SEPTEMBER 6, 2023
Jane Grogan, an industry veteran who worked at Genentech for over 15 years, will take over the role starting Oct. 2. She’ll fill a seat that's lacked a permanent replacement since the departure of Al Sandrock.
STAT
SEPTEMBER 28, 2023
New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.
Express Pharma
SEPTEMBER 12, 2023
JB Chemicals & Pharmaceuticals recently published its 2 nd Sustainability (ESG) Report. The report informs that the overall Green House Gases (GHG) intensity (i.e. Scope 1 and Scope 2) has been reduced by 19 per cent as compared to last year. A statement from the company informs, “This financial year also witnessed the completion of calculating scope 3 emissions for the first time for JB Pharma, where focus will be on total emissions across the organisation and the external supply chain.
Pharma Times
SEPTEMBER 8, 2023
Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate - News - PharmaTimes
The Pharmacist
SEPTEMBER 8, 2023
The Pharmacists’ Defence Association (PDA) has urged pharmacists to ask their employers to sign the Covid-19 safety pledge, which includes a commitment to ensuring that all workers who test positive for the virus are both asked to self-isolate and given adequate support to stay at home. The representative body itself has recently signed the pledge, […] The post Ask employers to sign Covid-19 safety pledge, urges PDA appeared first on The Pharmacist.
The Thyroid Pharmacist
SEPTEMBER 1, 2023
A few years ago, I visited with family in Poland. At that time, one of my cousins was attending dental school in the European Union. She asked me, “Izabella, is it true that the U.S. government adds fluoride to their water supply, in an effort to reduce dental cavities, instead of educating the public about the effect of sugar consumption and nutrition on health?
BioPharma Dive
SEPTEMBER 11, 2023
Pfizer and Moderna, which have seen slowing demand for their coronavirus vaccines, expect to make the reformulated shots available in the U.S. in the coming days.
STAT
SEPTEMBER 22, 2023
Late last summer, Elizabeth Jacques brought her youngest daughter, Elena, for a medical checkup. At the time, Jacques and her family were experiencing housing instability after a two-year legal battle with their former landlord, who refused to clean up their unsanitary, unlivable conditions. For Jacques, it was obvious she had to leave a housing situation that was putting her family’s health at risk.
Express Pharma
SEPTEMBER 17, 2023
The World Spice Congress hosted at Mumbai by the Spices Board of India saw the launch of a cardamom-based nutraceutical called Recovereez. Zum Heilen Diagnostic & Therapeutics, a startup company based in Thrissur in Kerala has developed the product and formulation and has been awarded the Indian patent. The product was launched by Amar Singh Bhatia IAS -Chairman Spices Board, D Sathyan, IFS – Secretary Spices Board, and Dr Remahsree, Director, Spices Board.
Pharma Times
SEPTEMBER 7, 2023
The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact - News - PharmaTimes
The Pharmacist
SEPTEMBER 15, 2023
Health minister Neil O’Brien has agreed to meet with community pharmacy stakeholders following a debate in parliament which centred on the significant challenges across the sector. The debate held yesterday was called by Conservative MP for Waveney Peter Aldous to highlight the role that community pharmacies play and to address the ‘enormous pressures’ they currently […] The post Health minister agrees to meet with pharmacy stakeholders appeared first on The Pharmacist.
Pharmaceutical Technology
SEPTEMBER 28, 2023
The company’s algorithms put proteins through millions of years of simulated evolution to identify potential functional candidates.
Expert insights. Personalized for you.
126 
Let's personalize your content